John Wiley & Sons, Inc., today announced that it will provide editorial production, global marketing and distribution services for The EMBO Journal, EMBO reports and Molecular Systems Biology. This expanded partnership with EMBO adds three leading scientific journals alongside EMBO Molecular Medicine, which Wiley has published since 2009.
The EMBO Journal is EMBO’s flagship title. Since its launch in 1982, the journal has maintained its position as one of the most influential for the publication of important research advances and authoritative reviews in molecular and cell biology.
EMBO reports publishes short-format papers in all research areas of molecular biology while offering broadly accessible scientific review and commentary, as well as a unique ‘Science and Society’ section that explores how science is shaping the world.
Molecular Systems Biology is the premier journal dedicated to the interdisciplinary fields of systems biology and synthetic biology. This fully open access title publishes research that focuses on the analysis, integration and modelling of molecular and cellular processes.
These titles will join EMBO Molecular Medicine, an open access journal dedicated to research at the interface of clinical research and the molecular life sciences. The journal publishes high-quality research advancing the understanding, prevention and treatment of human disease.
Together The EMBO Journal, EMBO reports, Molecular Systems Biology and EMBO Molecular Medicine span the whole spectrum of molecular biology, from structural biology and biophysics to medical research, from molecules to systems, and from viruses to humans.
All four titles will be available on the new EMBO Press platform hosted by HighWire Press of Stanford University and by Wiley Online Library. HighWire Press will connect the EMBO titles to some of the most prestigious journals in the life sciences. Wiley Online Library is the world’s broadest multidisciplinary collection of online resources, hosting over 4 million articles and 1,500 journals covering life, health, physical and social sciences.
All articles published by EMBO Molecular Medicine and Molecular Systems Biology, as well as EMBO Journal and EMBO reports articles where authors choose to publish open access, will be freely available to read, download and share. All articles are published in compliance with the requirements of the major funding organizations and open access articles are published under the terms of a Creative Commons Attribution License.
“We’re delighted to be building on the success of EMBO Molecular Medicine and to be working with EMBO on its entire journal portfolio,” said David Nicholson, Life Science Publishing Director, Wiley. “EMBO is known to stand for excellence in the life sciences and through this partnership Wiley will support the organization in promoting and disseminating world class research to a global audience.”
“We welcome Wiley and HighWire Press as partners to support the launch of EMBO Press,” said Bernd Pulverer, Head of Scientific Publications at EMBO. “EMBO Press will provide the independence and flexibility to serve optimally the scientific community and ensure that the EMBO scientific journals remain at the forefront of technological advancement and publication policy development in the years ahead.”
